We are live on ! Find out more
DICE

DICE Therapeutics, Inc. Common Stock
DICE

Delisted

DICE was delisted on the 8th of August, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of DICE yet.

DICE Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in DICE Therapeutics, Inc. Common Stock (DICE) for Q3 2023, worth a combined $0 — down 100% from $2.11B a quarter earlier.

Sellers outnumbered buyers: 159 funds closed out of DICE and 0 opened new positions — a net loss of 159 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RA Capital Management, exiting entirely with an estimated $365M sold.

  • 0 institutional investors held DICE Therapeutics, Inc. Common Stock (DICE) as of Q3 2023, down from 160 in Q2 2023.
  • Funds reported $0 of DICE Therapeutics, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new DICE Therapeutics, Inc. Common Stock positions in Q3 2023 and 159 closed out, a net change of -159 holders.
  • The largest DICE Therapeutics, Inc. Common Stock seller in Q3 2023 was RA Capital Management, an estimated $365M sold.

Based on aggregated 13F filings for Q3 2023.